"10.1371_journal.pone.0016923","plos one","2011-02-08T00:00:00Z","Yasuhiro Uno; Shotaro Uehara; Sakae Kohara; Kazuhide Iwasaki; Ryoichi Nagata; Koichiro Fukuzaki; Masahiro Utoh; Norie Murayama; Hiroshi Yamazaki","Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories, Ltd., Kainan, Japan; Business Development Department, Shin Nippon Biomedical Laboratories, Ltd., Osaka, Japan; Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Japan","Conceived and designed the experiments: YU HY. Performed the experiments: YU SU SK NM. Analyzed the data: YU SU NM. Wrote the paper: YU KI RN KF MU HY.","The authors have read the journal's policy and have the following potential conflicts: YU, SU, SK, KI, RN, KF, and MU are employed by Shin Nippon Biomedical Laboratories, Ltd. Due to the affiliation of these authors, there is a competing interest on the patent pending, regarding the newly identified CYP2C93 described in this manuscript. Yasuhiro Uno, Shotaro Uehara, Masahiro Utoh, and Shin Nippon Biomedical Laboratories, Ltd. filed this patent application in Japan (no. 2010-203775, date of filing September 10, 2010). However, this has no influence on the content of this article.","2011","02","Yasuhiro Uno","YU",9,TRUE,2,4,3,6,TRUE,TRUE,FALSE,0,NA,FALSE
